Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06489535 · ClinicalTrials.gov registry record · NA

Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)

A NA study of Opioid Use Disorder and Septic Arthritis, sponsored by Boston Medical Center.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06489535 is a NA study of Opioid Use Disorder and Septic Arthritis that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 40 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06489535, a NA study of Opioid Use Disorder and Septic Arthritis, is actively recruiting participants, sponsored by Boston Medical Center.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been adapted to better fit the experiences and unique issues of those that have been hospitalized with serious injection related infections (SIRI) based on the findings from a prior qualitative study from the principal investigator. This project plans to test the adapted intervention within a smaller group of participants to assess feasibility, acceptability, and calculate early findings of intervention efficacy. Hospitalizations for SIRIs are a unique entry point for patients to start their recovery journey with medications for OUD (MOUD), but many people do not remain on long-term treatment, despite evidence that indicates MOUDs reduce death and re-hospitalization after SIRIs. The study objectives are to: * Assess the implementation feasibility of the adapted RMC model for patients with SIRI and OUD. * Establish preliminary estimates of intervention efficacy. * Make further adaptions to the intervention that will reduce both known and unknown barriers to care and increase effectiveness in future larger scale trials. Findings from this pilot study will result in further intervention refinement to better fit the target population, and serve as the basis for a larger randomized control trial that will have aims focused on more in-depth analysis of the efficacy of this program

Interventions

  • OTHER RETAIN
  • OTHER Unrelated videos

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-01-06
Est. Completion 2026-03
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT06489535

The ClinicalTrials.gov registry entry for NCT06489535 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (99% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which RETAIN is the first listed.

NCT06489535 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06489535 about?

NCT06489535 is a clinical study titled "Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)". This project is a pilot study of an adapted intervention of an existing Opioid Use Disorder (OUD) treatment retention intervention called Recovery Management Checkups (RMC). This intervention has been adapted to better fit the experiences and unique issues of those that have been hospitalized with s...

What is the current status of trial NCT06489535?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-01-06. Estimated completion is 2026-03.

What conditions does trial NCT06489535 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Septic Arthritis, Osteomyelitis, Bloodstream Infection, Endocarditis.

What interventions are being tested in trial NCT06489535?

The interventions under investigation include: RETAIN (OTHER), Unrelated videos (OTHER).

Who is sponsoring clinical trial NCT06489535?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06489535 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.